Home NiKang Therapeutics

NiKang Therapeutics

In operation
Series C
Small Molecule Oncology Drug Developer

Basic Information

NiKang Therapeutics is an early-stage biotechnology company dedicated to the discovery and development of innovative small-molecule oncology medicines to help patients with unmet medical needs. Its discovery approach is based on target structural biology and utilizes structure-based drug design to enable rapid and efficient discovery and development of proprietary drug candidates with optimal pharmacological properties for clinical research.
NiKang Therapeutics, Inc.
Wilmington,Delaware,United States of America
15~50 people
January 01, 2017
info@nikangtx.com